Salem Investment Counselors’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,000
Closed -$120 1268
2024
Q4
$120 Hold
1,000
﹤0.01% 1180
2024
Q3
$138 Hold
1,000
﹤0.01% 1170
2024
Q2
$147 Hold
1,000
﹤0.01% 1140
2024
Q1
$146 Hold
1,000
﹤0.01% 1148
2023
Q4
$201 Hold
1,000
﹤0.01% 1080
2023
Q3
$168 Hold
1,000
﹤0.01% 1072
2023
Q2
$200 Hold
1,000
﹤0.01% 1114
2023
Q1
$212 Hold
1,000
﹤0.01% 1077
2022
Q4
$163 Hold
1,000
﹤0.01% 1055
2022
Q3
$0 Hold
1,000
﹤0.01% 1170
2022
Q2
$0 Hold
1,000
﹤0.01% 1164
2022
Q1
$0 Hold
1,000
﹤0.01% 1163
2021
Q4
$0 Hold
1,000
﹤0.01% 1147
2021
Q3
$1K Hold
1,000
﹤0.01% 961
2021
Q2
$1K Hold
1,000
﹤0.01% 890
2021
Q1
$2K Buy
+1,000
New +$1.63K ﹤0.01% 824

Other funds holding ZOM

Salem Investment Counselors's ZOM Position: Q1 2025 in Review

Salem Investment Counselors sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 1,000 shares — an estimated $120 sold.

Salem Investment Counselors first reported a position in ZOM in Q1 2021 and held it in 16 quarters. The position peaked at $2K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Salem Investment Counselors reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Salem Investment Counselors sold 1,000 Zomedica Corp. shares in Q1 2025, an estimated $120.
  • Salem Investment Counselors first reported a position in Zomedica Corp. in Q1 2021 and held it in 16 quarters.
  • Salem Investment Counselors's Zomedica Corp. position peaked at $2K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Salem Investment Counselors's 13F filing for Q1 2025, filed 16 Apr 2025.